» Articles » PMID: 35291973

A Case Report of Sanfilippo Syndrome - the Long Way to Diagnosis

Overview
Journal BMC Neurol
Publisher Biomed Central
Specialty Neurology
Date 2022 Mar 16
PMID 35291973
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mucopolysaccharidosis type III (Sanfilippo syndrome) is a lysosomal storage disorder, caused by a deficiency in the heparan-N-sulfatase enzyme involved in the catabolism of the glycosaminoglycan heparan sulfate. It is characterized by early nonspecific neuropsychiatric symptoms, followed by progressive neurocognitive impairment in combination with only mild somatic features. In this patient group with a broad clinical spectrum a significant genotype-phenotype correlation with some mutations leading to a slower progressive, attenuated course has been demonstrated.

Case Presentation: Our patient had complications in the neonatal period and was diagnosed with Mucopolysaccharidosis IIIa only at the age of 28 years. He was compound heterozygous for the variants p.R245H and p.S298P, the latter having been shown to lead to a significantly milder phenotype.

Conclusions: The diagnostic delay is even more prolonged in this patient population with comorbidities and a slowly progressive course of the disease.

Citing Articles

Sanfilippo Syndrome: Optimizing Care with a Multidisciplinary Approach.

Cyske Z, Anikiej-Wiczenbach P, Wisniewska K, Gaffke L, Pierzynowska K, Manski A J Multidiscip Healthc. 2022; 15:2097-2110.

PMID: 36158637 PMC: 9505362. DOI: 10.2147/JMDH.S362994.